Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer

Tsuyoshi, Hideaki; Tsujikawa, Tetsuya; Yamada, Shizuka; Okazawa, Hidehiko; Yoshida, Yoshio

doi:10.1186/s13550-020-00712-3

EJNMMI Research

Table 1 Characteristics of patients with primary ovarian cancer

From: Diagnostic value of [¹⁸F]FDG PET/MRI for staging in patients with ovarian cancer

Case	Age (years)	Histology	Pathological staging	PET/MRI staging	ceMRI and/or ceCT staging
1	40	Clear	T1N0M0	T1N0M0	T1N0M0
2	52	LGSC	T1N0M0	T1N0M0	T1N0M0
3	41	Clear	T1N0M0	T1N0M0	T1N0M0
4	47	Endometrioid	T3cN0M1	T3cN0M1	T3cN0M0
5	58	Seromucinous	T1N0M0	T1N0M0	T1N0M0
6	52	Clear	T2aN0M0	T1N0M0	T1N0M0
7	65	Mucinous borderline	T1N0M0	T1N0M0	T1N0M0
8	19	Immature teratoma, G1	T1N0M0	benign	benign
9	69	Clear	T1N0M0	T1N0M0	T1N0M0
10	42	Mucinous borderline	T1N0M0	T1N0M0	T1N0M0
11	45	HGSC	T2bN0M0	T1N0M0	T1N0M0
12	76	Mucinous borderline	T1N0M0	T1N0M0	T1N0M0
13	73	Sertoli–Leydig moderate	T1N0M0	T1N0M0	T1N0M0
14	31	Seromucinous borderline	T1N0M0	T1N0M0	T1N0M0
15	67	CS	T2aN1M1	T2aN1M1	T2aN1M0
16	77	HGSC	T3cN1M1	T3cN1M1	T3cN1M0
17	78	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
18	65	Endometrioid	T3cN0M0	T3cN0M0	T3cN0M0
19	56	Endometrioid	T2aN1M0	T2aN1M0	T2aN1M0
20	78	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
21	66	Clear	T1N0M0	T1N0M0	T1N0M0
22	43	Sertoli–Leydig poor	T1N0M0	T1N0M0	T1N0M0
23	20	Immature teratoma, G1	T1N0M0	T1N0M0	T1N0M0
24	62	CS	T3cN0M1	T3cN0M1	T3cN0M1
25	50	Mucinous borderline	T1N0M0	T1N0M0	T1N0M0
26	41	Serous borderline	T1N0M0	T1N0M0	T1N0M0
27	67	SCC	T1N1M1	T1N1M1	T1N0M0
28	63	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
29	54	Endometrioid	T1N0M0	T1N0M0	T1N0M0
30	71	HGSC	T3cN0M1	T3cN0M1	T3cN0M0
31	73	Serous borderline	T1N0M0	benign	benign
32	73	Undifferentiated carcinoma	T3cN0M1	T3cN0M1	T3cN0M1
33	23	Immature teratoma, G1	T1N0M0	T1N0M0	T1N0M0
34	31	Neuroendocrine carcinoma	T3cN0M0	T3cN0M0	T3cN0M0
35	38	Mucinous borderline	T1N0M0	T1N0M0	T1N0M0
36	53	Seromucinous borderline	T1N0M0	T1N0M0	T1N0M0
37	43	Endometrioid	T1N0M0	T1N0M0	T1N0M0
38	61	Mucinous	T1N0M0	T1N0M0	T1N0M0
39	51	Clear	T1N0M0	T1N0M0	T1N0M0
40	62	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
41	56	HGSC	T3bN0M0	T1N0M0	T1N0M0
42	68	SCC	T1N1M1	T1N1M1	T1N0M1
43	80	Undifferentiated carcinoma	T3cN1M1	T3cN1M1	T3cN1M0
44	56	Endometrioid	T1N0M0	T1N0M0	T1N0M0
45	51	Clear	T1N0M0	T1N0M0	T1N0M0
46	72	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
47	75	Adenocarcinoma	T3cN0M0	T3cN0M0	T3cN0M0
48	45	HGSC	T1N0M0	T1N0M0	T1N0M0
49	11	Immature teratoma G1	T1N0M0	T1N0M0	T1N0M0
50	76	Adenocarcinoma	T3cN0M1	T3cN0M1	T3cN0M0
51	48	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
52	65	HGSC	T3cN0M1	T3cN0M1	T3cN0M0
53	59	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
54	66	HGSC	T3cN0M1	T3cN0M1	T3cN0M0
55	64	HGSC	T3cN0M0	T3cN0M0	T3cN0M0
56	80	HGSC	T3cN0M1	T3cN0M1	T3cN0M0

Underlining indicates over- or under-diagnosis
G, grade; HGSC, high-grade serous carcinoma; LGSC, low-grade serous carcinoma; CS, carcinosarcoma; SCC, squamous cell carcinoma

Back to article page